Generic Drug Approvals: June 2004

• First Time Generic for Roxicodone
  Oxycodone Hydrochloride Tablets USP 15 mg and 30 mg
  Mallinckrodt, Inc. Approved: June 30, 2004
• Oxycodone Hydrochloride and Acetaminophen Tablets USP 7.5 mg/500 mg and 10 mg/650 mg
  Mallinckrodt, Inc. Approved: June 30, 2004
• Oxycodone and Acetaminophen Tablets USP 7.5 mg/325 mg and 10 mg/325 mg
  Mallinckrodt, Inc. Approved: June 30, 2004
• Lithium Carbonate Capsules USP 150 mg, 300 mg, and 600 mg
  Able Laboratories, Inc. Approved: June 29, 2004
• Propoxyphene Napsylate and Acetaminophen Tablets USP 100 mg/500 mg
  Vintage Pharmaceuticals, Inc. Approved: June 28, 2004
• First Time Generic for AccuNeb
  Albuterol Sulfate Inhalation Solution 0.042% (Base)
  Nephron Pharmaceuticals Corporation Approved: June 28, 2004
• Loratadine Tablets USP (OTC) 10 mg
  L. Perrigo Company Approved: June 25, 2004
• Carbidopa and Levodopa Extended-Release Tablets 50 mg/200 mg
  Kv Pharmaceutical Company Approved: June 24, 2004
• First Time Generic for Biaxin XL
  Clarithromycin Extended-Release Tablets 500 mg
  Andrx Pharmaceuticals, LLC Approved: June 24, 2004
• First Time Generic for Synthroid
  Levothyroxine Sodium Tablets USP 0.025 mg, 0.05 mg, 0.075 mg, 0.088 mg, 0.1 mg, 0.112 mg, 0.125 mg, 0.15 mg, 0.175 mg, 0.2 mg, and 0.3 mg
  Mylan Pharmaceuticals, Inc. Approved: June 23, 2004
• Econazole Nitrate Cream 1%
  Clay-Park Labs, Inc. Approved: June 23, 2004
• Ammonium Lactate Lotion 12% (Base)
  Clay-Park Labs, Inc. Approved: June 23, 2004
• Hydrocodone Bitartrate and Acetaminophen Tablets USP 10 mg/300 mg
  Mikart Inc. Approved: June 23, 2004
• Dimenhydrinate Injection USP 50 mg/mL; packaged In 1 mL and 10 mL Multiple-Dose Vials
  American Pharmaceutical Partners, Inc. Approved: June 23, 2004
• Metformin Hydrochloride Extended-Release Tablets 500 mg
  Ranbaxy Laboratories Limited Approved: June 18, 2004
• Metformin Hydrochloride Extended-Release Tablets 500 mg
  Teva Pharmaceuticals USA Approved: June 18, 2004
• Ibuprofen Tablets (OTC) 100 mg
  LNK International, Inc. Approved: June 17, 2004
• Carbidopa And Levodopa Extended-Release Tablets 25 mg/100 mg and 50 mg/200 mg
  Torpharm Inc. Approved: June 16, 2004
• Metformin Hydrochloride Extended-Release Tablets 500 mg
  Andrx Pharmaceuticals Approved: June 10, 2004
• Butalbital, Acetaminophen, Caffeine and Codeine Phosphate Capsules
  50 mg/325 mg/40 mg/30 mg
  Anabolic Laboratories Approved: June 10, 2004
• Doxazosin Mesylate Tablets 1 mg, 2 mg, 4 mg and 8 mg
  Clonmel Healthcare Approved: June 10, 2004
• First Time Generic for Ciloxan
  Ciprofloxacin Ophthalmic Solution 0.3%
  Bausch and Lomb Approved: June 9, 2004
• Ciprofloxacin Ophthalmic Solution 0.3%
  Novex Pharma Approved: June 9, 2004
• First Time Generic for Cipro
  
• Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
  Eon Labs, Inc. Approved: June 9, 2004
• Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
  Teva Pharmaceuticals USA Approved: June 9, 2004
• Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
  Carlsbad Technology, Inc. Approved: June 9, 2004
• Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
  Genpharm Inc. Approved: June 9, 2004
• Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
  Barr Laboratories, Inc. Approved: June 9, 2004
• Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
  Cobalt Pharmaceuticals Approved: June 9, 2004
• Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
  Dr. Reddy’s Laboratories, Inc. Approved: June 9, 2004
• Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
  Hikma Pharmaceuticals Approved: June 9, 2004
• Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
  IVAX Pharmaceuticals, Inc. Approved: June 9, 2004
• Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
  Martec Scientific Approved: June 9, 2004
• Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
  Mylan Pharmaceuticals Approved: June 9, 2004
• Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
  Ranbaxy Pharmaceuticals Approved: June 9, 2004
• Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
  Sandoz Scientific Approved: June 9, 2004

Generic Approvals Archive